drug: sodium oxybate (GHB) |
|
|
*| Clinical class | (putative) antialcoholic, anti cataplexy, antinarcoleptic, general anesthetic, hypnotic |
| Action | central nervous system depressant; GABAB agonist |
| Chemical class | gamma-aminobutyric acid (GABA) derivative |
| CSA schedule | III |
| DEA number | 2010 |
| Routes of administration | oral solution |
| Associated with (substance-related)
|
disorders: disorders (presumed, not extensively studied) |
| Availability | prescription (restricted) |
Also:
- 4-hydroxybutanoic acid, gamma-hydroxybutyrate, gamma hydroxybutyric acid, gamma-OH
- Project GHB
- CDER Xyrem information
U.S. Preparations:
- Xyrem® (Orphan) FDA
approved for: Treatment of cataplexy
in patients with
narcolepsy 7.17.2002
Treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy 11.18.2005
U.S. Prescribing information
International Preparations:
- Cernep
Street names:
- easy lay, Georgia Home Boyz, Georgia Home Brew, gib, Grievous Bodily Harm, G-riffic, liquid E, liquid ecstacy, liquid G, liquid X, natural sleep - 500, organic Quaalude, scoop, somatomax
*Molecule graphic courtesy of Steve Chapman